James E. Herndon

Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma.

H. S. Friedman, Demetrius M. Kokkinakis, James M. Pluda et al. · Journal of Clinical Oncology · 1998 · 217 citations · Full text

Medicine, Oncology, Pharmacology +16

Quality of life for adult leukemia survivors treated on clinical trials of cancer and leukemia group B during the period 1971-1988

Alice B. Kornblith, James E. Herndon, Enid Zuckerman et al. · Cancer · 1997 · 127 citations

Medicine, Oncology, Cancer Survivorship Care +9

Dosimetry and dose–response relationships in newly diagnosed patients with malignant gliomas treated with Iodine-131-Labeled anti-tenascin monoclonal antibody 81C6 therapy

Gamal Akabani, Ilkcan Cokgor, Robert E. Coleman et al. · International Journal of Radiation Oncology*Biology*Physics · 2000 · 69 citations

Medicine, Nuclear Medicine, Oncology +12

Modulation of O6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin: a phase I trial.

Timothy J. Panella, David C. Smith, S. Clifford Schold et al. · PubMed · 1992 · 25 citations

Medicine, Pharmacology, Pharmacotherapy +17